Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
for Metastatic Colorectal Cancer (CRC)
Drug: Bevacizumab
58 locations incl. Goodyear
Sponsor: Summit Therapeutics
Sex: All·Age: 18+
Code: NCT07228832·Phase 3·Recruiting